Seres Therapeutics Inc MCRB:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:48 PM EDT
3.31quote price arrow down-0.09 (-2.79%)
Volume
566,998
52 week range
3.22 - 25.05
Loading...
  • Open3.48
  • Day High3.52
  • Day Low3.24
  • Prev Close3.41
  • 52 Week High25.05
  • 52 Week High Date06/30/21
  • 52 Week Low3.22
  • 52 Week Low Date05/18/22

Key Stats

  • Market Cap305.74M
  • Shares Out92.23M
  • 10 Day Average Volume1.02M
  • Dividend-
  • Dividend Yield-
  • Beta3.48
  • YTD % Change-60.62

KEY STATS

  • Open3.48
  • Day High3.52
  • Day Low3.24
  • Prev Close3.41
  • 52 Week High25.05
  • 52 Week High Date06/30/21
  • 52 Week Low3.22
  • 52 Week Low Date05/18/22
  • Market Cap305.74M
  • Shares Out92.23M
  • 10 Day Average Volume1.02M
  • Dividend-
  • Dividend Yield-
  • Beta3.48
  • YTD % Change-60.62

RATIOS/PROFITABILITY

  • EPS (TTM)-0.97
  • P/E (TTM)-3.43
  • Fwd P/E (NTM)-1.48
  • EBITDA (TTM)-78.877M
  • ROE (TTM)-77.22%
  • Revenue (TTM)140.70M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-61.65%
  • Debt To Equity (MRQ)62.30%

EVENTS

  • Earnings Date08/01/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Seres Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Seres Therapeutics, Inc. is a microbiome therapeutics platform company. The Company is engaged in developing a class of biological drugs, which are designed to treat disease by modulating the microbiome to restore health by repairing the function of a disrupted microbiome to a non-disease state. The Company's lead product candidate, SER-109, is designed to reduce further recurrences of Clostridioides difficle infection (CDI). It is also developing therapeutics, such as...
Stephen Berenson
Independent Chairman of the Board
Eric Shaff
President, Chief Executive Officer, Director
David Arkowitz
Chief Financial Officer, Executive Vice President, Head of Business Development
David Ege Ph.D.
Executive Vice President, Chief Technology Officer
John Aunins Ph.D.
Executive Vice President - Bioprocess and Manufacturing, Chief Technology Officer
Address
200 Sidney St
Cambridge, MA
02139-4218
United States

Top Peers

SYMBOLLASTCHG%CHG
ADMA
ADMA Biologics Inc
2.02-0.04-1.71%
PGEN
Precigen Inc
1.23-0.02-2.00%
HRTX
Heron Therapeutics Inc
3.48-0.09-2.66%
RIGL
Rigel Pharmaceuticals Inc
2.00-0.12-5.75%
CLVS
Clovis Oncology Inc
0.6733-0.04-5.6077%